Table 2.

Clinical and pathological data of patients with CRC that contributed tissues for immunohistochemical analysis

Patient No.	Age(year)	Gender	pTNM	pStaging	Tumor location
1	67	F	TisN0M0	Stage 0	A
2	66	F	TisN0M0	Stage 0	D
3	61	F	TisN0M0	Stage 0	S
4	70	M	TisN0M0	Stage 0	T
5	64	F	TisN0M0	Stage 0	T
6	63	M	T2N0M0	Stage I	Rb
7	58	F	T2N0M0	Stage I	Rb
8	45	F	T2N0M0	Stage I	Rb
9	67	F	T2N0M0	Stage I	Ra
10	87	F	T2N0M0	Stage I	Ra
11	67	F	T2N0M0	Stage I	S
12	70	M	T1N0M0	Stage I	S
13	75	F	T1N0M0	Stage I	T
14	82	M	T1N0M0	Stage I	T
15	63	M	T3N0M0	Stage IIA	S
16	53	M	T3N0M0	Stage IIA	S
17	77	F	T3N0M0	Stage IIA	S
18	53	M	T3N0M0	Stage IIA	S
19	76	F	T3N0M0	Stage IIA	S
20	51	M	T3N0M0	Stage IIA	A
21	52	M	T3N0M0	Stage IIA	Ra
22	69	M	T3N0M0	Stage IIA	T
23	69	F	T3N0M0	Stage IIA	S
24	92	M	T3N0M0	Stage IIA	T
25	64	M	T2N1aM0	Stage IIIA	Ra
26	73	F	T2N1bM0	Stage IIIA	Ra
27	64	M	T3N1aM0	Stage IIIB	Ra
28	50	F	T3N1bM0	Stage IIIB	S
29	51	M	T3N1bM0	Stage IIIB	A
30	64	M	T3N1aM0	Stage IIIB	S
31	64	F	T3N1bM0	Stage IIIB	Ra
32	78	F	T3N1aM0	Stage IIIB	A
33	72	F	T4aN1AM0	Stage IIIB	C
34	52	M	T3N1bM0	Stage IIIB	Ra
35	85	F	T4bN1aM0	Stage IIIC	A
36	70	M	T4aN2aM0	Stage IIIC	S
37	81	F	T4aN0M1a	Stage IVA	T
38	71	F	T4aN2aM1a	Stage IVA	A
39	49	M	T3N2aM1a	Stage IVA	C
40	78	M	T3N1bM1a	Stage IVA	Ra
41	77	M	T4aN2aM1a	Stage IVA	T
42	57	M	T3N2bM1b	Stage IVB	Ra
43	72	F	T4aN0M1b	Stage IVB	D
44	71	F	T4bN2bM1b	Stage IVB	C
45	70	M	T3N0M1b	Stage IVB	S

M male, F female, A ascending colon, T transverse colon, S sigmoid colon, Ra upper rectum, Rb lower rectum, D descending colon, C cecum